[Federal Register Volume 66, Number 83 (Monday, April 30, 2001)]
[Notices]
[Pages 21403-21404]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10638]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

[HCFA-3066-N]


Medicare Program; Meeting of the Diagnostic Imaging Panel of the 
Medicare Coverage Advisory Committee--June 19, 2001

<BD>AGENCY: <RM>Health Care Financing Administration (HCFA), HHS.

<BD>ACTION: <RM>Notice of meeting.

-----------------------------------------------------------------------

<BD>SUMMARY: <RM>This notice announces a public meeting of the 
Diagnostic Imaging Panel (the Panel) of the Medicare Coverage Advisory 
Committee. The Panel provides advice and recommendations to the agency 
about clinical issues. The Panel will hear and discuss presentations 
from interested persons regarding FDG Positron Emission Tomography 
imaging for breast cancer diagnosis and staging.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

<BD>DATES: <IT>The Meeting: <RM>The meeting will be held on June 19, 
2001 from 8 a.m. until 4:30 p.m., E.D.T.
    <IT>Deadline for Presentations and Comments: <RM>June 5, 2001, 5 
p.m., E.D.T.
    <IT>Special Accommodations: <RM>Persons attending the meeting who 
are hearing or visually impaired, or have a condition that requires 
special assistance or accommodations, are asked to notify the Executive 
Secretary by May 26, 2001.

<BD>ADDRESSES: <IT>The Meeting: <RM>The meeting will be held at the 
Baltimore Convention Center, Room 321 and 322, One West Pratt Street, 
Baltimore, MD 21201.
    <IT>Presentations and Comments: <RM>Submit formal presentations and 
written comments to Janet A. Anderson, Executive Secretary; Office of 
Clinical Standards and Quality; Health Care Financing Administration; 
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
    <IT>Website: <RM>You may access up-to-date information on this 
meeting at <IT>www.hcfa.gov/coverage.
    Hotline: <RM>You may access up-to-date information on this meeting 
on the HCFA Advisory Committee Information Hotline, 1-877-449-5659 
(toll free) or in the Baltimore area (410) 786-9379.

<BD>FOR FURTHER INFORMATION CONTACT: <RM>Janet A. Anderson, Executive 
Secretary, 410-786-2700.

<BD>SUPPLEMENTARY INFORMATION: <RM>On August 13, 1999, we published a 
notice (64 FR

[[Page 21404]]

44231) to describe the Medicare Coverage Advisory Committee (MCAC), 
which provides advice and recommendations to us about clinical issues. 
This notice announces the following public meeting of the Diagnostic 
Imaging Panel (the Panel) of MCAC.

Current Panel Members

    Frank Papatheofanis, MD, PhD; Barbara McNeil, MD, PhD; Carole 
Flamm, MD, MPH; Jeffrey Lerner, PhD; Michael Manyak, MD; Donna Novak, 
BA; Manuel Cerqueira, MD; Kim Burchiel, MD; Steven Guyton, MD; Sally 
Hart, JD; Michael Klein, MBA

Meeting Topic

    The Panel will hear and discuss presentations from interested 
persons regarding FDG Positron Emission Tomography imaging for breast 
cancer diagnosis and staging.

Procedure and Agenda

    This meeting is open to the public. The Panel will hear oral 
presentations from the public for approximately 1.5 hours. The Panel 
may limit the number and duration of oral presentations to the time 
available. If you wish to make formal presentations, you must notify 
the respective Executive Secretary listed in the <BD>FOR FURTHER 
INFORMATION CONTACT <RM>section of this notice, and submit the 
following by the Deadline for Presentations and Comments date listed in 
the <BD>DATES <RM>section of this notice: A brief statement of the 
general nature of the evidence or arguments you wish to present, and 
the names and addresses of proposed participants. A written copy of 
your presentation must be provided to each panel member prior to 
offering your public comments. We will request that you declare at the 
meeting whether or not you have any financial involvement with 
manufacturers of any items or services being discussed (or with their 
competitors).
    After the public and HCFA presentations, the Panel will deliberate 
openly on the topic. Interested persons may observe the deliberations, 
but the Panel will not hear further comments during this time except at 
the request of the chairperson. The Panel will also allow approximately 
a 30-minute open public session for any attendee to address issues 
specific to the topic. At the conclusion of the day, the members will 
vote and the Panel will make its recommendation.

    <CS>Authority: <RM>5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare--Supplementary Medical Insurance Program)

    Dated: April 6, 2001.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 01-10638 Filed 4-27-01; 8:45 am]
BILLING CODE 4120-01-P